154 related articles for article (PubMed ID: 2447576)
1. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities.
Bogart MH; Pandian MR; Jones OW
Prenat Diagn; 1987 Nov; 7(9):623-30. PubMed ID: 2447576
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
Crossley JA; Aitken DA; Connor JM
Prenat Diagn; 1991 Feb; 11(2):83-101. PubMed ID: 1712100
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy.
Bartels I; Thiele M; Bogart MH
Am J Med Genet; 1990 Oct; 37(2):261-4. PubMed ID: 2147362
[TBL] [Abstract][Full Text] [Related]
5. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
[TBL] [Abstract][Full Text] [Related]
6. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies.
Johnson A; Cowchock FS; Darby M; Wapner R; Jackson LG
Prenat Diagn; 1991 Jul; 11(7):443-50. PubMed ID: 1721715
[TBL] [Abstract][Full Text] [Related]
7. First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone.
Kratzer PG; Golbus MS; Monroe SE; Finkelstein DE; Taylor RN
Prenat Diagn; 1991 Oct; 11(10):751-63. PubMed ID: 1724801
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
9. Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies.
Blundell G; Ashby JP; Martin C; Shearing CH; Langdale-Brown B; Keeling J; Ellis PM; Shade M; Chambers SE; Wenham PR
Prenat Diagn; 1999 Mar; 19(3):219-23. PubMed ID: 10210119
[TBL] [Abstract][Full Text] [Related]
10. Velamentous umbilical cord insertion may be suspected from maternal serum alpha-fetoprotein and hCG.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Br J Obstet Gynaecol; 1996 Mar; 103(3):209-13. PubMed ID: 8630303
[TBL] [Abstract][Full Text] [Related]
11. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
12. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
13. Maternal urinary beta-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy.
Hayashi M; Kozu H
Prenat Diagn; 1995 Jan; 15(1):11-6. PubMed ID: 7537878
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
15. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
16. First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders. The Dutch Working Party on Prenatal Diagnosis.
Van Lith JM
Prenat Diagn; 1992 Jun; 12(6):495-504. PubMed ID: 1387477
[TBL] [Abstract][Full Text] [Related]
17. First-trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Dutch Working Party on Prenatal Diagnosis.
Van Lith JM
Prenat Diagn; 1994 Oct; 14(10):963-71. PubMed ID: 7534926
[TBL] [Abstract][Full Text] [Related]
18. Amniotic fluid levels of human chorionic gonadotropin and its alpha and beta subunits in second-trimester chromosomally abnormal pregnancies.
Wolf GC; Byrn FW; McConnell TS; Khazaeli MB
Prenat Diagn; 1992 Feb; 12(2):93-101. PubMed ID: 1372734
[TBL] [Abstract][Full Text] [Related]
19. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
Lepage N; Chitayat D; Kingdom J; Huang T
Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
[TBL] [Abstract][Full Text] [Related]
20. Multiple marker screening in multifetal gestations: failure to predict adverse pregnancy outcomes.
Drugan A; O'Brien JE; Dvorin E; Krivchenia EL; Johnson MP; Sokol RJ; Evans MI
Fetal Diagn Ther; 1996; 11(1):16-9. PubMed ID: 8719716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
